Table 2.
Baseline outcomes of participants with impaired fasting glucose in a quasi-experimental intervention study.
| Kelulut honey | Control | All | |
|---|---|---|---|
| Duration of IFG (years) | 1.6 ± 1.3 | 1.0 ± 1.2 | 1.3 ± 1.3 |
| Hypertension | |||
| Yes | 11 (36.7) | 12 (40) | 23 (38.3) |
| No | 19 (63.3) | 18 (60) | 37 (61.7) |
| Hypercholesterolaemia | |||
| Yes | 22 (73.3) | 25 (83.3) | 47 (78.3) |
| No | 8 (26.6) | 5 (16.7) | 13 (21.7) |
| Body mass index | 29.5 ± 4.8 | 29.8 ± 5.6 | 29.7 ± 5.2 |
| Fasting blood glucose (mmol/L) | 6.2 ± 1.4 | 6.2 ± 1.0 | 6.2 ± 1.2 |
| Total cholesterol (mmol/L) | 5.3 ± 1.2 | 5.2 ± 0.9 | 5.3 ± 1.0 |
| High-density lipoprotein (mmol/L) | 1.2 ± 0.3 | 1.3 ± 0.3 | 1.3 ± 1.2 |
| Low-density lipoprotein (mmol/L) | 3.4 ± 1.3 | 3.3 ± 0.8 | 3.4 ± 1.1 |
| Triglycerides∗ (mmol/L) | 1.5 (1.1) | 1.4 (0.9) | 1.4 (1.1) |
| Systolic blood pressure (mmHg) | 134.9 ± 14.6 | 133.8 ± 12.1 | 134.9 ± 13.1 |
| Diastolic blood pressure (mmHg) | 86.3 ± 9.4 | 83.0 ± 9.7 | 85.1 ± 9.5 |
Values are mean ± SD of observed findings. ∗Median (IQR).